Viewing Study NCT06505538



Ignite Creation Date: 2024-10-26 @ 3:35 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06505538
Status: COMPLETED
Last Update Posted: None
First Post: 2024-03-01

Brief Title: Nurse-Led Mobile App Effect on Symptom Management for Breast Cancer Patients After Surgery
Sponsor: None
Organization: None

Study Overview

Official Title: Nurse-Led Mobile App Effect on Symptom Management for Breast Cancer Patients After Surgery A Quasi-Experimental Study
Status: COMPLETED
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Background The use of the Nurse-Led Mobile App NL-Mapp is a current and important option for educating patients about the symptoms that may arise from breast cancer surgery

Introduction Given the precise information and counseling services offered to breast cancer patients NL-Mapp is considered an appropriate choice to support postoperative self-care

Methods This quasi-experimental study aimed to determine the impact of NL-Mapp on breast cancer patients after surgery The study included 45 patients in the intervention group and 45 patients in the control group First NL-Mapp was developed by the research team Patients were then taught how to use the app to manage their symptoms after breast cancer surgery and online counseling was provided for patients questions The intervention started before surgery and follow-up visits were made before discharge and in the first month
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None